Get started
Work

Correction: Outcomes among newly diagnosed AL amyloidosis patients with a very high NT-proBNP: implications for trial design

Year: 2024
Type: erratum
Abstract: The Funding information section was missing from this article and should have read ‘This work was supported by the Paul Calabresi K12 Career Development Award (CA90628-21) and in part by Grant Number P30 CA015083 and CA186781 from the National Cancer Institute and by the Predolin Foundation and the JABBS Foundation.’.
Source: Leukemia
DOI: 10.1038/s41375-024-02311-w
Authors: I. Vaxman, S. K. Kumar, F. Buadi, M. Q. Lacy, D. Dingli, Y. Hwa, A. Fonder, M. Hobbs, S. Hayman, T. Kourelis, R. Warsame, E. Muchtar, N. Leung, P. Kapoor, M. Grogan, R. Go, Y. Lin, W. Gonsalves, M. Siddiqui, R. A. Kyle, S. V. Rajkumar, M. A. Gertz, A. Dispenzieri
Language: English
Open Access status: hybrid
Estimated APC paid: $4,990
OpenAlex ID: W4399739362
Cites:
Cited by:
Related to: 10